Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,159.50
Market cap
₹1,16,673 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.9×Sector 47.4×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:13 IST BSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.

Value
₹55.46 Cr
12:27 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences received a demand for ₹108.54 Crore in deficient stamp duty and penalties. The company is evaluating legal remedies regarding the order.

Value
₹10.85 Cr
18:11 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences' subsidiary ZHL secured favorable appellate orders dropping GST demands totaling ₹0.42 Crore. This significantly reduces the company's potential tax liability and penalty exposure.

Value
₹0.42 Cr
17:18 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences received an appeal order upholding a ₹1.18 Crore GST demand and penalty. The company intends to file a second appeal before GSTAT.

Value
₹1.18 Cr
09:41 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences' subsidiary, Zydus VTEC Limited, received a GST demand and penalty order totaling ₹1.80 Crore for the period September 2020 to March 2023. The issue pertains to alleged inadmissible Input Tax Credit. The company intends to appeal the order and states there is no material financial impact.

Value
₹1.80 Cr
22:31 IST BSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences' subsidiary, GRPPL, received an appellate order dropping a previously imposed GST penalty of ₹0.17 Crore (Rs. 1.66 million) for FY 2018-19. The Office of Commissioner (Appeals) Ahmedabad set aside the demand, resulting in no material impact on the company's financials or operations.

Value
₹0.17 Cr
15:05 IST BSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences received a favorable order from the GST Adjudication Authority, Gandhinagar, dropping a tax demand of ₹4.18 Crore for FY 2019-20. The company noted the event is not material under SEBI regulations and was disclosed as a good governance practice.

Value
₹4.18 Cr
18:08 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences Limited received a favourable order from the GST Adjudication Authority in Gandhinagar. The order dropped a GST demand of ₹4.18 Crore (Rs. 41.77 million) for the financial year 2019-20. This positive regulatory outcome reduces the company's potential tax liabilities.

Value
₹4.18 Cr